Animation - Understanding Biomarker Testing in NSCLC
Slide Show - Understanding Biomarker Testing in NSCLC
1.
What is 'comprehensive biomarker testing'?
2.
What is comprehensive biomarker testing for lung cancer? What do I need to know?
3.
What is a driver mutation?
4.
How is biomarker testing carried out?
5.
When should biomarker testing be done in NSCLC?
6.
Which biomarkers exist for NSCLC?
7.
What happens if my tumor tests positive? What happens if it doesn’t test positive for a biomarker?
8.
What if I have already had a biopsy and my tumor was not tested for biomarkers?
9.
What should newly diagnosed lung cancer patients do if biomarker testing is not offered to them?
10.
Why is biomarker testing so important for certain ethnic groups, such as African Americans?
11.
How can we close the gaps to make sure all NSCLC patients get tested?
Expert Video - How can we close the gaps to make sure all NSCLC patients get tested?
Robert Winn, MD, director of the Massey Cancer Center at Virginia Commonwealth University, discusses the disparity in care for metastatic non-small-cell lung cancer between Black and White Americans and describes various ways to close this and other gaps, including through clinical trial participation, routine biomarker testing, patient education and involvement, and knowledge of the potential of precision medicine for lung cancer treatment.
Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about lung cancer which will help other patients, caregivers and families.
Section: Biomarker Testing in NSCLC
Expert Videos
Animation - Understanding Biomarker Testing in NSCLC
Slide Show - Understanding Biomarker Testing in NSCLC
1.
What is 'comprehensive biomarker testing'?
2.
What is comprehensive biomarker testing for lung cancer? What do I need to know?
3.
What is a driver mutation?
4.
How is biomarker testing carried out?
5.
When should biomarker testing be done in NSCLC?
6.
Which biomarkers exist for NSCLC?
7.
What happens if my tumor tests positive? What happens if it doesn’t test positive for a biomarker?
8.
What if I have already had a biopsy and my tumor was not tested for biomarkers?
9.
What should newly diagnosed lung cancer patients do if biomarker testing is not offered to them?
10.
Why is biomarker testing so important for certain ethnic groups, such as African Americans?
11.
How can we close the gaps to make sure all NSCLC patients get tested?
